BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17139886)

  • 21. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes.
    Thibodeau SN; French AJ; Roche PC; Cunningham JM; Tester DJ; Lindor NM; Moslein G; Baker SM; Liskay RM; Burgart LJ; Honchel R; Halling KC
    Cancer Res; 1996 Nov; 56(21):4836-40. PubMed ID: 8895729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
    Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon YJ; Daver A; Chassevent A; Bernard-Gallon DJ
    Anticancer Res; 2005; 25(3B):2009-16. PubMed ID: 16158938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.
    Konishi M; Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Onda A; Okumura Y; Kishi N; Iwama T; Mori T; Koike M; Ushio K; Chiba M; Nomizu S; Konishi F; Utsunomiya J; Miyaki M
    Gastroenterology; 1996 Aug; 111(2):307-17. PubMed ID: 8690195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
    Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
    Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability.
    Akiyama Y; Iwanaga R; Ishikawa T; Sakamoto K; Nishi N; Nihei Z; Iwama T; Saitoh K; Yuasa Y
    Cancer; 1996 Dec; 78(12):2478-84. PubMed ID: 8952554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking.
    Brand RM; Jones DD; Lynch HT; Brand RE; Watson P; Ashwathnayaran R; Roy HK
    World J Gastroenterol; 2006 Jul; 12(28):4485-91. PubMed ID: 16874859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of hMLH1 or hMSH2 expression as a stage-dependent prognostic factor in sporadic colorectal cancers.
    Park JW; Chang HJ; Park S; Kim BC; Kim DY; Baek JY; Kim SY; Oh JH; Choi HS; Park SC; Jeong SY
    Ann Surg Oncol; 2010 Nov; 17(11):2839-46. PubMed ID: 20549564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
    Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
    Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two types of sporadic multiple colorectal cancers with and without HNPCC-like genetic instability.
    Komura K; Masuda H; Esumi M
    Hepatogastroenterology; 1999; 46(30):3115-20. PubMed ID: 10626171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.
    Vageli D; Daniil Z; Dahabreh J; Karagianni E; Vamvakopoulou DN; Ioannou MG; Scarpinato K; Vamvakopoulos NC; Gourgoulianis KI; Koukoulis GK
    Lung Cancer; 2009 Jun; 64(3):282-8. PubMed ID: 19056144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.
    Wright CL; Stewart ID
    Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial genomic instability in colorectal cancer: no correlation to nuclear microsatellite instability and allelic deletion of hMSH2, hMLH1, and p53 genes, but prediction of better survival for Dukes' stage C disease.
    Tsai MH; Fang WH; Lin SW; Yen SJ; Chou SJ; Yang YC
    Ann Surg Oncol; 2009 Oct; 16(10):2918-25. PubMed ID: 19582509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss or somatic mutations of hMSH2 occur in hereditary nonpolyposis colorectal cancers with hMSH2 germline mutations.
    Lu SL; Akiyama Y; Nagasaki H; Nomizu T; Ikeda E; Baba S; Ushio K; Iwama T; Maruyama K; Yuasa Y
    Jpn J Cancer Res; 1996 Mar; 87(3):279-87. PubMed ID: 8613431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer.
    Tanyi M; Olasz J; Lukács G; Csuka O; Tóth L; Szentirmay Z; Ress Z; Barta Z; Tanyi JL; Damjanovich L
    World J Gastroenterol; 2006 Feb; 12(8):1192-7. PubMed ID: 16534870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence.
    Velasco A; Hewitt SM; Albert PS; Hossein M; Rosenberg H; Martinez C; Sagalowsky AI; McConnell JD; Marston W; Leach FS
    Cancer; 2002 Feb; 94(3):690-9. PubMed ID: 11857301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.
    Leach FS; Velasco A; Hsieh JT; Sagalowsky AI; McConnell JD
    J Urol; 2000 Nov; 164(5):1830-3. PubMed ID: 11025778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients.
    Chai SM; Zeps N; Shearwood AM; Grieu F; Charles A; Harvey J; Goldblatt J; Joseph D; Iacopetta B
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):1017-25. PubMed ID: 15551255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
    Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
    Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.